WO2012108650A3 - 뇌졸중의 치료제 또는 진단제로서 프로테이나아제-3에 대한 단클론 항체의 용도 - Google Patents
뇌졸중의 치료제 또는 진단제로서 프로테이나아제-3에 대한 단클론 항체의 용도 Download PDFInfo
- Publication number
- WO2012108650A3 WO2012108650A3 PCT/KR2012/000854 KR2012000854W WO2012108650A3 WO 2012108650 A3 WO2012108650 A3 WO 2012108650A3 KR 2012000854 W KR2012000854 W KR 2012000854W WO 2012108650 A3 WO2012108650 A3 WO 2012108650A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteinase
- stroke
- monoclonal antibody
- agent
- therapeutic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 뇌졸중의 치료제 또는 진단제로서 프로테이나아제-3에 대한 단클론 항체의 용도에 관한 것이다.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2011-0012057 | 2011-02-10 | ||
| KR1020110012057A KR101262251B1 (ko) | 2011-02-10 | 2011-02-10 | 뇌졸중의 치료제 또는 진단제로서 프로테이나아제-3에 대한 단클론 항체의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012108650A2 WO2012108650A2 (ko) | 2012-08-16 |
| WO2012108650A3 true WO2012108650A3 (ko) | 2012-10-26 |
Family
ID=46639035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2012/000854 WO2012108650A2 (ko) | 2011-02-10 | 2012-02-06 | 뇌졸중의 치료제 또는 진단제로서 프로테이나아제-3에 대한 단클론 항체의 용도 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR101262251B1 (ko) |
| WO (1) | WO2012108650A2 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104297489A (zh) * | 2014-08-20 | 2015-01-21 | 苏州和锐医药科技有限公司 | 一种抗pr3-anca抗体检测试纸的制备方法及用途 |
| FR3102175B1 (fr) * | 2019-10-18 | 2021-10-01 | Univ Tours | Nouveaux anticorps monoclonaux therapeutiques humains et leurs utilisations |
-
2011
- 2011-02-10 KR KR1020110012057A patent/KR101262251B1/ko not_active IP Right Cessation
-
2012
- 2012-02-06 WO PCT/KR2012/000854 patent/WO2012108650A2/ko active Application Filing
Non-Patent Citations (4)
| Title |
|---|
| DATABASE NCBI 19 March 1999 (1999-03-19), accession no. M 002777 * |
| DOMINIQUE BORIES ET AL.: "Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells", CELL, vol. 59, no. 6, 1989, pages 959 - 968 * |
| W.-J. MAYET ET AL.: "Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells", CLIN. EXP. IMMUNOL., vol. 94, no. 3, 1993, pages 440 - 446 * |
| Y. M. VAN DER GELD ET AL.: "Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies", CLIN. EXP. IMMUNOL., vol. 118, no. 3, 1999, pages 487 - 496 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012108650A2 (ko) | 2012-08-16 |
| KR20120091936A (ko) | 2012-08-20 |
| KR101262251B1 (ko) | 2013-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122278T1 (el) | Αντι il-36r αντισωματα | |
| WO2011123489A3 (en) | Anti-cd40 antibodies | |
| MX356337B (es) | Anticuerpos contra csf-1r humano y sus usos. | |
| HK1202431A1 (en) | Humanized pan-her antibody compositions pan-her | |
| ECSP13012649A (es) | Anticuerpos ANTI-IL-23 | |
| CO7020875A2 (es) | Anticuerpos humanizados que reconocen la alfa-sinucleina | |
| IL230564B1 (en) | Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses. | |
| CL2014000574A1 (es) | Anticuerpo monoclonal humanizado que se une al complejo aßtcr/cd3 humano. | |
| GB2504139B (en) | Antibodies to highly conserved targets produced by the immunisation of Camelidae species | |
| PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
| SG178886A1 (en) | Humanized anti-cdcp1 antibodies | |
| GB201103836D0 (en) | Conjugation process | |
| MX2014002996A (es) | Anticuerpos anti - egfr/anti - igf-1r bisespecificos. | |
| WO2012104823A3 (en) | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases | |
| CR20120553A (es) | Anticuerpos il-25 humanizados | |
| WO2012149334A3 (en) | Methods and compositions for the generation and use of conformation-specific antibodies | |
| EP2694539A4 (en) | POLYCLONAL ANTIBODY COMPOSITIONS | |
| WO2015023508A3 (en) | Methods for improving asthma symptoms using benralizumab | |
| PL2814843T3 (pl) | Ludzkie przeciwciała monoklonalne neutralizujące IL-β | |
| MX2012010443A (es) | Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos. | |
| ZA201305946B (en) | Diagnostic antibody assay | |
| WO2012108650A3 (ko) | 뇌졸중의 치료제 또는 진단제로서 프로테이나아제-3에 대한 단클론 항체의 용도 | |
| WO2012122513A3 (en) | Generation of anti-fn14 monoclonal antibodies by ex-vivo accelerated antibody evolution | |
| WO2013030654A8 (en) | Processes for the preparation of (r)-2-acetamido-n-benzyl-3-methoxypropionamide and intermediates thereof | |
| WO2013011062A3 (en) | Antagonistic antibodies against oscar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12745283 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12745283 Country of ref document: EP Kind code of ref document: A2 |